 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Alterity Therapeutics Limited
ATHE
|
131 |
$ 5.15 |
15.21 % |
$ 12.4 B |
Australia |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Applied Therapeutics
APLT
|
54.1 |
- |
- |
$ 8.42 M |
USA |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Aligos Therapeutics
ALGS
|
30.2 |
$ 6.51 |
-2.54 % |
$ 64.4 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.73 |
$ 22.92 |
0.17 % |
$ 1.07 B |
USA |
 |
BioNTech SE
BNTX
|
35.7 |
$ 105.19 |
2.21 % |
$ 27.2 B |
Germany |
 |
Aravive
ARAV
|
6.61 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 |
$ 3.0 |
-1.32 % |
$ 4.94 M |
Israel |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AstraZeneca PLC
AZN
|
2.17 |
- |
- |
$ 96.9 B |
Britain |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
1.42 |
$ 1.43 |
1.78 % |
$ 368 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Aquestive Therapeutics
AQST
|
10.5 |
$ 4.24 |
-1.85 % |
$ 453 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 |
$ 24.47 |
-0.24 % |
$ 3.11 B |
USA |
 |
Burford Capital Limited
BUR
|
6.35 |
$ 4.99 |
0.6 % |
$ 804 M |
Britain |
 |
AIkido Pharma
AIKI
|
0.935 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
4.27 |
$ 1.58 |
-1.25 % |
$ 420 M |
Britain |
 |
BioXcel Therapeutics
BTAI
|
24 |
$ 1.2 |
4.35 % |
$ 14.6 M |
USA |
 |
Cabaletta Bio
CABA
|
50.3 M |
$ 3.31 |
-3.92 % |
$ 333 M |
USA |
 |
bluebird bio
BLUE
|
2.27 |
- |
- |
$ 546 M |
USA |
 |
Fennec Pharmaceuticals
FENC
|
3.78 |
$ 6.73 |
-0.88 % |
$ 192 M |
USA |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
CymaBay Therapeutics
CBAY
|
110 |
- |
- |
$ 3.45 B |
USA |
 |
Cidara Therapeutics
CDTX
|
116 |
- |
- |
$ 1.41 B |
USA |
 |
ChromaDex Corporation
CDXC
|
4.32 |
- |
-0.88 % |
$ 598 M |
USA |